Next Article in Journal
Middle Cerebral Artery Stroke as Amusement Park Injury: Case Report and Review of the Literature
Next Article in Special Issue
The Fetus Can Teach Us: Oxygen and the Pulmonary Vasculature
Previous Article in Journal
DSM-5 Changes in Attention Deficit Hyperactivity Disorder and Autism Spectrum Disorder: Implications for Comorbid Sleep Issues
Previous Article in Special Issue
Sildenafil in Infants and Children
Article Menu

Export Article

Open AccessReview
Children 2017, 4(8), 63; https://doi.org/10.3390/children4080063

Persistent Pulmonary Hypertension in the Newborn

Department of Pediatrics, University at Buffalo, Buffalo, NY 14222, USA
*
Author to whom correspondence should be addressed.
Received: 2 June 2017 / Revised: 18 July 2017 / Accepted: 25 July 2017 / Published: 28 July 2017
(This article belongs to the Special Issue New Trend in Pediatric Cardiology: Pulmonary Hypertension)
View Full-Text   |   Download PDF [2030 KB, uploaded 31 July 2017]   |  

Abstract

Persistent pulmonary hypertension of the newborn (PPHN) is a syndrome of failed circulatory adaptation at birth due to delay or impairment in the normal fall in pulmonary vascular resistance (PVR) that occurs following birth. The fetus is in a state of physiological pulmonary hypertension. In utero, the fetus receives oxygenated blood from the placenta through the umbilical vein. At birth, following initiation of respiration, there is a sudden precipitous fall in the PVR and an increase of systemic vascular resistance (SVR) due to the removal of the placenta from circulation. There is dramatic increase in pulmonary blood flow with a decrease in, and later reversal of shunts at the foramen ovale and ductus arteriosus. The failure of this normal physiological pulmonary transition leads to the syndrome of PPHN. PPHN presents with varying degrees of hypoxemic respiratory failure. Survival of infants with PPHN has significantly improved with the use of gentle ventilation, surfactant and inhaled nitric oxide (iNO). PPHN is associated with significant mortality and morbidity among survivors. Newer agents that target different enzymatic pathways in the vascular smooth muscle are in different stages of development and testing. Further research using these agents is likely to further reduce morbidity and mortality associated with PPHN. View Full-Text
Keywords: oxygen; hypoxemia; nitric oxide; pulmonary blood flow oxygen; hypoxemia; nitric oxide; pulmonary blood flow
Figures

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).
SciFeed

Share & Cite This Article

MDPI and ACS Style

Mathew, B.; Lakshminrusimha, S. Persistent Pulmonary Hypertension in the Newborn. Children 2017, 4, 63.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Children EISSN 2227-9067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top